دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Funnel plots of patient?reported outcomes to evaluate health?care quality: Basic principles, pitfalls and considerations
Esmee M. van der Willik Erik W. van Zwet Tiny Hoekstra Frans J. van Ittersum Marc H. Hemmelder Carmine Zoccali Kitty J. Jager Friedo W. Dekker Yvette Meuleman
doi : 10.1111/nep.13761
Volume 26, Issue 2, February 2021, Pages: 95-104
The statistical review provides insights into the use and interpretation of funnel plots by presenting an overview of the basic principles, pitfalls and considerations when applied to patient?reported outcomes using examples from Dutch routine dialysis care.
Recommendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF?PH inhibitors
Desmond Y. H. Yap Lawrence P. McMahon Chuan?Ming Hao Nan Hu Hirokazu Okada Yusuke Suzuki Sung Gyun Kim Soo Kun Lim Kriengsak Vareesangthip Chi?Chih Hung Masaomi Nangaku for the APSN HIF?PHI Recommendation Committee
doi : 10.1111/nep.13835
Volume 26, Issue 2, February 2021, Pages: 105-118
The Asian Pacific society of nephrology HIF?PHI Recommendation Committee summarizes the consensus views of the committee regarding the use of HIF?PHI, taking into account both available data and expert opinion in areas where evidence remains scarce.
Glucocorticoid effects on bone strength in children with renal diseases
Jun Aoyagi Takahiro Kanai Takane Ito Jun Odaka Takashi Saito Hiroyuki Betsui Masanori Kurosaki Tomomi Maru Takanori Yamagata
doi : 10.1111/nep.13832
Volume 26, Issue 2, February 2021, Pages: 119-125
This study examined the effects of glucocorticoids (GCs) on bone strength in children with steroid ?sensitive nephrotic syndrome and IgA nephropathy, and revealed that (a) serum alkaline phosphatase (S?ALP) is a more sensitive bone quality marker than tartrate?resistant acid phosphatase 5b (S?TRACP?5b), (b) bone mineral density loss was observed only when both S?ALP and S?TRACP?5b levels decreased, and (c) undercarboxylated osteocalcin levels do not directly reflect bone strength.
Diagnostic accuracy of fibroblast growth factor 23 for predicting acute kidney injury in patients with acute decompensated heart failure
Nattha Pramong Pongsathorn Gojaseni Sarunyoo Suttipongkeat Kraiwiporn Kiattisunthorn Anutra Chittinandana
doi : 10.1111/nep.13780
Volume 26, Issue 2, February 2021, Pages: 126-133
In this single centre cohort study, plasma FGF?23 was found to predict AKI in the setting of acute decompensated heart failure. The results could propel further research to explore this biomarker in this high risk AKI setting.
Rituximab in treatment of collapsing FSGS—A case series
Niveditha Girimaji Joyita Bharati Ritambhra Nada Manish Rathi Harbir Singh Kohli Raja Ramachandran
doi : 10.1111/nep.13757
Volume 26, Issue 2, February 2021, Pages: 134-141
This is a retrospective study reporting the effects of Rituximab on 8 patients with the collapsing form of focal segmental glomerulosclerosis. Whilst retrospective in nature, the study suggested that rituximab might be a promising form of treatment for this condition, which is traditionally resistant to immunosuppression therapy, resulting in a remission rate of 60% with a reasonable safety profile.
Aetiology, practice patterns and burden of end?stage kidney disease in South Asia and South?East Asia: A questionnaire?based survey
Manisha Sahay Sanjiv Jasuja Sydney Chi Wai Tang Suceena Alexander Vivekanand Jha Tushar Vachharajani Mamun Mostafi Jayakrishnan K. Pisharam Chakko Jacob Atma Gunawan Goh Bak Leong Khin Thida Thwin Rajendra Kumar Agrawal Kriengsak Vareesangthip Roberto Tanchanco Lina Choong Chula Herath Chih?Ching Lin Nguyen The Cuong Ha Phan Haian Syed Fazal Akhtar Ali Alsahow Devinder S. Rana Mohan M. Rajapurkar Vijay Kher Shalini Verma Raja Ramachandran Vinant Bhargava Sonika Puri Gaurav Sagar Anupam Bahl Sandeep Mandal Ashwani Gupta Maurizio Gallieni
doi : 10.1111/nep.13825
Volume 26, Issue 2, February 2021, Pages: 142-152
There are few data on the epidemiology and pattern of practice for end?stage kidney disease from South Asia and South?East Asia. This survey covers 15 Asian countries and provide important information on how ESKD patients are managed in this part of the world.
Variability and trends over time and across centres in haemodialysis weekly duration in Australia and New Zealand
Isabelle Ethier Yeoungjee Cho Christopher E. Davies Carmel M. Hawley Scott B. Campbell Nicole M. Isbel Elaine M. Pascoe Kevan R. Polkinghorne Matthew Roberts Emily J. See David Semple Carolyn van Eps Andrea K. Viecelli David W. Johnson
doi : 10.1111/nep.13782
Volume 26, Issue 2, February 2021, Pages: 153-163
Patient?level characteristics such as age, sex, BMI, dialysis vintage, ethnicity rather than centre?level ones were associated with weekly duration of haemodialysis, with more variability among home? than in?centre haemodialysis patients in the Australian and New Zealand population.
Calcium?mediated parathyroid hormone suppression test in uraemic secondary hyperparathyroidism
Ting Xiang Yan Wang Tian Lan Li Zhou
doi : 10.1111/nep.13807
Volume 26, Issue 2, February 2021, Pages: 164-169
In a study on 44 patients with kidney failure on dialysis undergoing parathryoidectomy for hypercalcaemia, the parathyroid hormone?inhibition rate with intravenous calcium gluconate had a negative correlation with parathyroid mass. This interesting non?invasive test needs validation in larger studies.
Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines
Diana Beatriz S. Bayani Bernadette Joy Q. Almirol Geovin Dexter C. Uy Mary Joy S. Taneo Romina S. Danguilan Mel?Hatra I. Arakama Arlene B. Lamban Donnah de Leon Glenda Eleanor P. Pamugas Alia Cynthia Luz Yot Teerawatananon
doi : 10.1111/nep.13830
Volume 26, Issue 2, February 2021, Pages: 170-177
This article aims to identify a cost?effective policy strategy for access to kidney replacement therapy in the Philippines, and calls on the government to consider shifting to a Peritoneal Dialysis (PD)?First strategy and support policies that promote kidney transplants among existing PD and haemodialysis patients.
Levofloxacin based non?rifampicin anti?tuberculous therapy: An effective alternative in renal transplant recipients in resource limited setting
Krishan Lal Gupta Sahil Bagai Harsha Kumar Saurabh Nayak Valliappan Muthu Vivek Kumar Manish Rathi Harbir S Kohli Ashish Sharma Raja Ramachandran
doi : 10.1111/nep.13816
Volume 26, Issue 2, February 2021, Pages: 178-184
In this single?centre study, the authors report their experience using levofloxacin instead of rifampicin for the treatment of tuberculosis after kidney transplantation. Therapy with levofloxacin appeared safe and effective, and may provide a more cost?effective treatment for post?transplant tuberculosis in financially constrained clinical settings.
Influence of end stage renal disease on CD28 expression and T?cell immunity
Erasmia Sampani Maria Stangou Dimitra?Vasilia Daikidou Vasiliki Nikolaidou Despoina Asouchidou Chrysostomos Dimitriadis George Lioulios Aliki Xochelli Asimina Fylaktou Aikaterini Papagianni
doi : 10.1111/nep.13784
Volume 26, Issue 2, February 2021, Pages: 185-196
End stage renal disease affects specific T?cell subtypes, including CD4+CD28null and CD8+CD28null cells. Although changes in T?cell subpopulations were present before the initiation of dialysis, they were also affected by dialysis modalities, with results favouring continuous ambulatory peritoneal dialysis.
Advances in understanding the role of adiponectin in renal fibrosis
Dan Zhao Xiaoyu Zhu Lili Jiang Xiu Huang Yangyang Zhang Xuejiao Wei Xiaoxia Zhao Yujun Du
doi : 10.1111/nep.13808
Volume 26, Issue 2, February 2021, Pages: 197-203
This review focuses on the potential renoprotective role of the adipocyte?produced protein, adiponectin, and raises awareness of how increasing adiponectin activity may provide a possible strategy for delaying or abrogating renal fibrosis. The pathways through which adiponectin mediates its anti?fibrotic effects are also detailed.
Rapidly progressive metastatic adenocarcinoma of unknown primary 2 months following deceased donor renal transplantation—Donor? or recipient?derived?
Lachlan C. McMichael Robert P. Carroll Nitesh N. Rao Patrick Toby Coates
doi : 10.1111/nep.13777
Volume 26, Issue 2, February 2021, Pages: 204
Absent erythropoietin response to anaemia with mild to moderate chronic kidney disease in pregnancy
Adam Morton
doi : 10.1111/nep.13779
Volume 26, Issue 2, February 2021, Pages: 205
